Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Metabolism And Disposition

• Publication date

  2016-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.115.066746PMID 26842596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variable Selection

  2019cited by this paper
• Ethnic Variability in the Expression of Hepatic Drug Transporters: Absolute Quantification by an Optimized Targeted Quantitative Proteomic Approach

  2015cited by this paper
• Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure.

  2015cited by this paper
• Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data

  2014cited by this paper
• Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions

  2014cited by this paper
• Quantitative Transporter Proteomics by Liquid Chromatography with Tandem Mass Spectrometry: Addressing Methodologic Issues of Plasma Membrane Isolation and Expression-Activity Relationship

  2014cited by this paper
• Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes.

  2013cited by this paper
• Multidrug resistance-associated protein 2 (MRP2/ABCC2)

  2013cited by this paper
• Membrane Protein Quantification by Peptide-Based Mass Spectrometry Approaches: Studies on the Organic Anion-Transporting Polypeptide Family

  2013cited by this paper
• ATP-dependent transport of statins by human and rat MRP2/Mrp2.

  2013cited by this paper
• Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition I: Characterization of Basolateral Versus Biliary Clearance Using a Novel Protocol in Sandwich-Cultured Hepatocytes

  2013influential reference
• Neutrophil Chemotaxis Caused by Chronic Obstructive Pulmonary Disease Alveolar Macrophages: The Role of CXCL8 and the Receptors CXCR1/CXCR2

  2013cited by this paper
• Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA

  2013cited by this paper
• Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans.

  2013cited by this paper
• Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin

  2013cited by this paper
• Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients

  2013cited by this paper
• Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

  2012cited by this paper
• Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model

  2012cited by this paper
• Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1

  2012influential reference
• Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.

  2012cited by this paper
• In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

  2011cited by this paper
• Development of a Highly Sensitive Method Using Liquid Chromatography-Multiple Reaction Monitoring to Quantify Membrane P-Glycoprotein in Biological Matrices and Relationship to Transport Function

  2011cited by this paper
• Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake

  2011cited by this paper
• Identification of the Rate‐Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

  2011cited by this paper
• OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture.

  2011cited by this paper
• Pitavastatin - pharmacological profile from early phase studies.

  2010cited by this paper
• Solving Differential Equations in R: Package deSolve

  2010cited by this paper
• Regularization Paths for Generalized Linear Models via Coordinate Descent.

  2010cited by this paper
• Inverse Modelling, Sensitivity and Monte Carlo Analysis in R Using Package FME

  2010cited by this paper
• Foreword: From the local organizing chair ISCD2

  2010cited by this paper
• Hepatobiliary Disposition of Troglitazone and Metabolites in Rat and Human Sandwich-Cultured Hepatocytes: Use of Monte Carlo Simulations to Assess the Impact of Changes in Biliary Excretion on Troglitazone Sulfate Accumulation

  2010cited by this paper
• Isolation and culture of primary hepatocytes from resected human liver tissue.

  2010cited by this paper
• Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors

  2009cited by this paper
• LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species.

  2009cited by this paper
• Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry.

  2008cited by this paper
• Dynamic localization of hepatocellular transporters in health and disease.

  2008cited by this paper
• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  2008cited by this paper
• Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.

  2008cited by this paper
• SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers

  2007cited by this paper
• Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport

  2006cited by this paper
• Transporters on Demand: Intracellular Reservoirs and Cycling of Bile Canalicular ABC Transporters*

  2006cited by this paper
• Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin

  2005cited by this paper
• Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin

  2005cited by this paper
• Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans

  2004cited by this paper
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003cited by this paper
• Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase--effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice.

  2002cited by this paper
• Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration.

  1999cited by this paper
• Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells.

  1998cited by this paper
• Transport function and substrate specificity of multidrug resistance protein.

  1998cited by this paper
• Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles

  1996cited by this paper

• Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics

  2025cites this paper
• Impact of Obesity and MASH on Zonal Hepatocellular Statin Exposure: Pharmacodynamic Insights From a Permeability‐Limited Multicompartment Liver Model

  2025cites this paper
• Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier

  2024cites this paper
• Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method

  2023cites this paper
• Mechanistic Static Model based Prediction of Transporter Substrate Drug-Drug Interactions Utilizing Atorvastatin and Rifampicin

  2023cites this paper
• The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans.

  2022cites this paper
• Comparative Hepatic and Intestinal Efflux Transport of Statins

  2021cites this paper
• Application of proteomic data in the translation of in vitro observations to associated clinical outcomes.

  2021cites this paper
• Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations

  2021cites this paper
• Biofabrication of size-controlled liver microtissues incorporated with ECM-derived microparticles to prolong hepatocyte function

  2021cites this paper
• Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations

  2021cites this paper
• Proteomics‐Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight

  2020cites this paper
• Successful prediction of PET-imaged metformin hepatic uptake clearance in humans using the quantitative proteomics-informed relative expression factor approach

  2020influential citation
• Transient, tunable expression of NTCP and BSEP in MDCKII cells for kinetic delineation of the rate-determining process and inhibitory effects of rifampicin in hepatobiliary transport of taurocholate.

  2020cites this paper
• Evaluation of hepatic uptake of OATP1B substrates by short term-cultured plated human hepatocytes: Comparison with isolated suspended hepatocytes.

  2020cites this paper
• A tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research.

  2020cites this paper
• Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers.

  2020cites this paper
• Use of imaging to assess the activity of hepatic transporters

  2020cites this paper
• Successful Prediction of Positron Emission Tomography–Imaged Metformin Hepatic Uptake Clearance in Humans Using the Quantitative Proteomics–Informed Relative Expression Factor Approach

  2020cites this paper
• Proteomic evaluation of plasma membrane fraction prepared from mouse liver and kidney using a bead homogenizer: Enrichment of drug-related transporter proteins.

  2020cites this paper
• Cell-to-Medium Concentration Ratio Overshoot in the Uptake of Statins by Human Hepatocytes in Suspension, but Not in Monolayer: Kinetic Analysis Suggesting a Partial Loss of Functional OATP1Bs

  2020cites this paper
• Changes in Organic Anion Transporting Polypeptide Uptake in HEK293 Overexpressing Cells in the Presence and Absence of Human Plasma

  2019cites this paper
• Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes

  2019cites this paper
• Bottom-up physiologically-based biokinetic modelling as an alternative to animal testing.

  2019cites this paper
• Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.

  2019cites this paper
• Biotransformation and bioactivation reactions – 2018 literature highlights

  2019cites this paper
• Improvements for the in Vitro to in Vivo Extrapolation of Hepatic Clearance

  2019cites this paper
• Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice.

  2019cites this paper
• Characterization of parameters influencing intracellular bioavailability and prediction of intracellular drug exposure

  2019cites this paper
• Clinical Significance and Regulatory Framework for the Evaluation of Organic Anion Transporting Polypeptide 1B-Based Drug-Drug Interactions

  2019cites this paper
• Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling

  2018influential citation
• Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC‐MS/MS Proteomics

  2018cites this paper
• Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation

  2018cites this paper
• A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes

  2018cites this paper
• Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes

  2018cites this paper
• The Importance of Incorporating OCT2 Plasma Membrane Expression and Membrane Potential in IVIVE of Metformin Renal Secretory Clearance

  2018cites this paper
• Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates

  2018cites this paper
• Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics

  2018cites this paper
• Total hepatocellular disposition profiling of rosuvastatin and pitavastatin in sandwich-cultured human hepatocytes.

  2018cites this paper
• Pitavastatin: A Potent Drug

  2018cites this paper
• Substrate and method dependent inhibition of three ABC‐transporters (MDR1, BCRP, and MRP2)

  2017cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Intracellular drug bioavailability: a new predictor of system dependent drug disposition

  2017cites this paper
• Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic

  2017cites this paper
• In Vitro Evaluation of the Pharmacokinetic Effects of BCRP Interactions

  2017influential citation
• A Clinical Cassette Dosing Study for Evaluating the Contribution of Hepatic OATPs and CYP3A to Drug-Drug Interactions

  2017cites this paper
• Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.

  2017cites this paper
• Recent Progress in Hepatocyte Culture Models and Their Application to the Assessment of Drug Metabolism, Transport, and Toxicity in Drug Discovery: The Value of Tissue Engineering for the Successful Development of a Microphysiological System.

  2017cites this paper
• Optimization and Application of a Biotinylation Method for Quantification of Plasma Membrane Expression of Transporters in Cells

  2017cites this paper
• Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation

  2016cites this paper
• Intracellular unbound drug concentrations : methodology and application for understanding cellular drug exposure

  2016cites this paper
• Methodology and application for understanding cellular drug exposure

  2016cites this paper
• In vitro and in silico Predictions of Hepatic Transporter-Mediated Drug Clearance and Drug-Drug Interactions in vivo

  2015cites this paper
• Acta Universitatis Upsaliensis Uppsala 2016

  year unknowncites this paper